Earnings

EBIT and EBITDA

Earnings before interest and tax (EBIT) improved year on year to reach €414.8 million (€137.6 million). EBIT included budgeted negative effects from purchase price allocations totaling €41.8 million (H1 2020: €44.8 million). Non-recurring items amounting to an expense of €5.5 million were also recognized in the period under review and related in part to the capacity and structural program. The prior-year figure, an expense of €22.3 million, mainly included components of the capacity and structural program as well as an impairment charge on an equity investment. Earnings before interest and tax adjusted for non-recurring items and purchase price allocation effects (adjusted EBIT) amounted to €462.2 million for the first six months of 2021, which was more than double the figure for the first half of 2020 of €204.8 million. The adjusted EBIT margin recovered to 9.3 percent (H1 2020: 5.2 percent).

EBIT

in € million

Q2
2021

Q2
2020

Q1 – Q2
2021

in % of revenue

Q1 – Q2
2020

in % of revenue

EBIT

221.3

17.5

414.8

8.4%

137.6

3.5%

Adjustment by functional costs:

 

 

 

 

 

 

+ Cost of sales

9.4

10.3

18.9

0.4%

20.3

0.5%

+ Selling expenses and administrative expenses

15.1

22.0

29.5

0.6%

35.7

0.9%

+ Research and development costs

0.0

0.0

0.1

0.0%

0.1

0.0%

+ Other costs

1.4

10.9

–1.1

0.0%

11.0

0.3%

Adjusted EBIT

247.2

60.7

462.2

9.3%

204.8

5.2%

adjusted for non-recurring items

5.0

20.6

5.5

0.1%

22.3

0.6%

adjusted for PPA items

20.9

22.7

41.8

0.8%

44.8

1.1%

Earnings before interest, tax, depreciation, and amortization (EBITDA) rose to €873.9 million (H1 2020: €597.1 million). Adjusted EBITDA increased to €879.5 million (H1 2020: €619.4 million), giving an adjusted EBITDA margin of 17.7 percent (H1 2020: 15.8 percent).

EBITDA

in € million

Q2
2021

Q2
2020

Q1 – Q2
2021

in % of revenue

Q1 – Q2
2020

in % of revenue

EBITDA

452.7

247.8

873.9

17.6%

597.1

15.2%

Adjustment by functional costs:

 

 

 

 

 

 

+ Cost of sales

0.0

–0.1

0.0

0.0%

–0.1

0.0%

+ Selling expenses and administrative expenses

3.6

9.8

6.6

0.1%

11.4

0.3%

+ Research and development costs

0.0

0.0

0.0

0.0%

0.0

0.0%

+ Other costs

1.4

10.9

–1.0

0.0%

11.0

0.3%

Adjusted EBITDA

457.7

268.4

879.5

17.7%

619.4

15.8%

adjusted for non-recurring items

5.0

20.6

5.6

0.1%

22.3

0.6%

adjusted for PPA items

0.0

0.0

0.0

0.0%

0.0

0.0%

EBITDA for the long-term leasing business, which is derived from internal reporting and assumes a minimum rate of return on the capital employed, amounted to €170.0 million in the reporting period (H1 2020: €167.7 million).